NCT02835833 2018-07-10Study of Nintedanib Plus Bevacizumab in Advanced Solid TumorsUniversity of Alabama at BirminghamPhase 1 Completed21 enrolled
NCT02278978 2015-05-12BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial CarcinomaNational Taiwan University HospitalPhase 2 Unknown129 enrolled